IRIS
NAPOLITANO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.997
EU - Europa 3.596
AS - Asia 2.723
SA - Sud America 32
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 11.385
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.974
CN - Cina 2.465
IE - Irlanda 1.108
UA - Ucraina 660
DE - Germania 382
IT - Italia 380
FI - Finlandia 367
SE - Svezia 332
SG - Singapore 191
GB - Regno Unito 166
FR - Francia 130
JP - Giappone 31
BR - Brasile 24
CA - Canada 21
MU - Mauritius 20
RU - Federazione Russa 20
BE - Belgio 17
NL - Olanda 15
IN - India 11
IR - Iran 6
EU - Europa 5
ZA - Sudafrica 5
AR - Argentina 4
CZ - Repubblica Ceca 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
GR - Grecia 3
HK - Hong Kong 3
AU - Australia 2
BD - Bangladesh 2
CH - Svizzera 2
CL - Cile 2
ET - Etiopia 2
TN - Tunisia 2
AM - Armenia 1
AT - Austria 1
CY - Cipro 1
EC - Ecuador 1
ES - Italia 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
VE - Venezuela 1
Totale 11.385
Salva come PNG Salva come JPEG
Città #
Dublin 1.108
Chandler 1.040
Jacksonville 854
Nanjing 716
Boardman 371
Ashburn 358
Nanchang 301
Princeton 259
Lawrence 233
Wilmington 222
Hebei 219
Changsha 187
Shenyang 183
Beijing 170
Jiaxing 151
Medford 148
Singapore 132
Helsinki 118
Tianjin 117
Shanghai 103
Hangzhou 86
Milan 84
Woodbridge 82
San Genesio Ed Uniti 69
Ann Arbor 63
New York 57
Norwalk 47
Falls Church 45
Verona 41
Seattle 33
Pavia 26
Des Moines 25
Tokyo 24
Chicago 22
Los Angeles 22
Houston 21
Fairfield 19
Kunming 19
Zhengzhou 18
Brussels 17
Jinan 14
Toronto 14
Washington 13
Ningbo 12
Tappahannock 11
Dearborn 10
Changchun 9
Guangzhou 9
Palermo 9
Rome 9
Taizhou 9
Munich 8
Auburn Hills 7
Falkenstein 7
Orange 7
Pune 6
Somma Lombardo 6
Borås 5
Dallas 5
Kobe 5
Lanzhou 5
Monza 5
Piscataway 5
Zola Predosa 5
Alghero 4
Castel Volturno 4
Phoenix 4
Redmond 4
Santa Clara 4
São Paulo 4
Barreiro 3
Berlin 3
Brno 3
Chengdu 3
Chongqing 3
Como 3
Dresden 3
Fuzhou 3
Genoa 3
Hong Kong 3
London 3
Mountain View 3
Naples 3
Novara 3
Nuremberg 3
Pozzuolo Martesana 3
Rockville 3
San Francisco 3
Ypsilanti 3
Addis Ababa 2
Andover 2
Bari 2
Bex 2
Bologna 2
Boves 2
Cremona 2
Desio 2
Forest City 2
Gavardo 2
Genova 2
Totale 8.108
Salva come PNG Salva come JPEG
Nome #
Tachicardia Ventricolare Polimorfa Catecolaminergica 134
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 122
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 108
A method of gene transfer for the treatment of recessive CPVT 104
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 94
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 81
Patient-tailored Workflow Patterns from Clinical Practice Guidelines Recommendations. 79
Risk stratification in the Long-QT Syndrome 78
Computer simulation of wild-type and mutant human cardiac Na+ current 78
Gene-specific therapy for inherited arrhythmogenic diseases 76
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 75
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 73
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 72
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 71
Cardiac Sodium Channel Diseases 70
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 68
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 67
Inherited arrhythmia: present and future perspectives for genetic therapy 67
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 66
Supporting shared decision making within the MobiGuide project. 66
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 66
Interplay between Clinical Guidelines and Organizational Workflow Systems. Experience from the MobiGuide project 66
Assessment of a personalized and distributed patient guidance system 66
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 65
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 65
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 65
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 64
Molecular underpinning of ''good luck'' 63
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 63
“Cardiac Risk Stratification by NOS1AP Genotyping” 63
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 63
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 63
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 63
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 63
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 62
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 62
Timothy Syndrome 62
R Engine Cell: integrating R into the i2b2 software infrastructure. 62
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 62
Evaluation of BLS-D training in lay people. 61
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 61
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 61
Combining decision support system-generated recommendations with interactive guideline visualization for better informed decisions 61
Information extraction from Italian medical reports: An ontology-driven approach 61
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 61
Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. 60
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 60
Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. 59
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 59
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype 59
L-TYPE CALCIUM CHANNEL DISEASE 59
Long QT Syndrome 58
A Recessive Variant of the Romano-Ward Long QT Syndrome 58
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers 58
Brugada syndrome 58
Experimental Therapy of genetic arrhythmias: disease-specific pharmacology. 57
Genetics of Arrhythmogenic Disorders 57
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 57
Novel Arrhythmogenic mechanism revealed by Long-QT Syndrome mutation in the Cardiac NA+ Channel 57
Letter regarding article by Coronel et al, ''right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study'' 56
Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: insights from a RyR2 R4496C knock-in mouse model 56
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? 56
Genetics of ion-channel disorders 56
Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes 56
Impact of molecular biology on diagnosis and management of arrhythmogenic disordes. 56
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 56
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 56
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 56
Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies 55
Significance of QT Dispersion in the Long QT Syndrome 55
Patient-tailored workflow patterns from clinical practice guidelines recommendations 55
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age 55
MobiGuide: a personalized and patient-centric decision-support system and its evaluation in the atrial fibrillation and gestational diabetes domains 55
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism 54
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation 54
Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. 54
Catecholaminergic Polymorphic Ventricular Tachycardia 54
The long QT syndrome 54
[Computerized tomography study of 32 patients with disk hernia confirmed during surgical intervention]. 54
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 54
Concealed arrhythmogenic syndromes: the hidden substrate of idiopathic ventricular fibrillation? 53
Genetics of Cardiovascular Diseases 53
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 53
Inherited calcium channelopathies in the pathophysiology of arrhythmias. 53
Cardiac Ion Channel Diseases: Clinical Impact 53
RyRCa Leak Limits Cardiac Ca Windows Current Overcoming the Tonic Effect of Calmodulin Mice. 53
Evaluation of QT dispersion in the clinical practice: a critical review 53
Low penetrance mutations and compound heterozygosity in LQTS: phenotypic consequences and implications for the clinical presentation of the disease 53
BRUGADA SYNDROME AND CONDUCTION SYSTEM DISEASE ARE LINKED TO A SINGLE SODIUM CHANNEL MUTATION. 52
When is genetic testing useful in patients suspected to have inherited cardiac arrhythmias? 52
Homozygous Deletion in KVLQT1 Associated With Jervell and Lange-Nielsen Syndrome. 52
Viral Gene Transfer Rescues Arrhythmogenic Phenotype and Ultrastructural Abnormalities in Adult Calsequestrin-Null Mice With Inherited Arrhythmias 52
Evaluation of spatial aspects of T-wave complexity in the Long QT syndrome 52
Sodium current disorders: Geneticist's view 52
Long QT syndrome in adults. 52
Brugada Syndrome and Sudden Cardiac Death in Children. 51
ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe 51
In the RyR2R4496C Mouse Model of CPVT, {beta}-Adrenergic Stimulation Induces Ca Waves by Increasing SR Ca Content and Not by Decreasing the Threshold for Ca Waves. 51
Genetic and molecular basis of arrhythmias. 51
Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor (RyR2) 51
Totale 6.239
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.910
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020465 0 0 0 0 0 0 8 149 8 189 108 3
2020/20211.307 144 125 44 123 2 175 10 186 77 196 171 54
2021/20221.003 8 2 16 6 27 55 34 59 82 51 155 508
2022/20233.090 363 193 42 260 289 350 2 146 1.298 18 78 51
2023/20241.169 137 175 55 103 107 315 53 63 5 24 36 96
2024/2025761 58 271 68 88 78 155 43 0 0 0 0 0
Totale 11.552